United Therapeutics Corporation (UTHR) financial statements (2022 and earlier)

Company profile

Business Address 1040 SPRING ST
SILVER SPRING, MD 20910
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9311,8351,4861,4169271,051954
Cash and cash equivalents8957397386697051,023832
Short-term investments1,0361,09674874722228122
Receivables199157151176297215193
Inventory, net of allowances, customer advances and progress billings94879310110810081
Inventory94879310110810081
Other current assets10088134751166047
Total current assets:2,3242,1671,8651,7681,4481,4251,275
Noncurrent Assets
Property, plant and equipment781732739700546489496
Long-term investments and receivables1,6501,150768443503238
Long-term investments1,6501,150768443503238
Intangible assets, net (including goodwill), including:45158158171463428
Goodwill28282832141010
Intangible assets, net (excluding goodwill)(6)(6)(5)(5)(9)(9)3
Other undisclosed intangible assets, net (including goodwill)22136136144413216
Deferred income tax assets262239230
Other noncurrent assets108170155224224197154
Deferred tax assets, net96113178193
Total noncurrent assets:2,8462,4482,0491,6331,432901909
TOTAL ASSETS:5,1694,6153,9133,4012,8792,3262,184
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities175187148166171104103
Accounts payable441023888
Accrued liabilities1711831391431639696
Debt  252   5
Other liabilities28404038343457
Other undisclosed current liabilities102972372240195275
Total current liabilities:305323463277445333441
Noncurrent Liabilities
Long-term debt and lease obligation800800600    
Long-term debt, excluding current maturities800800600    
Liabilities, other than long-term debt10597706764131144
Other liabilities10597706764131144
Other undisclosed noncurrent liabilities   250250  
Total noncurrent liabilities:905897670317314131144
Total liabilities:1,2101,2201,133593758463585
Temporary equity, carrying amount   19191111
Stockholders' equity
Stockholders' equity attributable to parent3,9593,3952,7802,7892,1021,8511,589
Common stock1111111
Treasury stock, value(2,579)(2,579)(2,579)(2,579)(2,579)(2,380)(1,902)
Additional paid in capital2,2452,1492,0481,9401,8541,8141,791
Accumulated other comprehensive loss(23)(14)(14)(8)(20)(17)(20)
Retained earnings4,3153,8393,3253,4352,8462,4341,720
Total stockholders' equity:3,9593,3952,7802,7892,1021,8511,589
TOTAL LIABILITIES AND EQUITY:5,1694,6153,9133,4012,8792,3262,184

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,6861,4831,4491,6281,7251,5991,466
Revenue, net1,7251,5991,466
Cost of revenue(590)(359)(391)(199)(315)(73)(418)
Cost of goods and services sold(123)(108)(118)(199)(106)(73)(69)
Other undisclosed gross profit467      
Gross profit:1,5631,1241,0581,4291,4101,5261,048
Operating expenses(540)(531)(1,245)(624)(595)(464)(349)
Other undisclosed operating loss(467)      
Operating income (loss):556594(188)8058151,062699
Nonoperating income (expense)384523(47)(45)(2)345
Investment income, nonoperating17294429(50)  
Other nonoperating income (expense)424923(8)1320
Interest and debt expense(19)(24)(44)(14)(9)(4)(5)
Income (loss) from continuing operations before equity method investments, income taxes:575615(209)7457611,0561,040
Other undisclosed income from continuing operations before income taxes19244414945
Income (loss) from continuing operations before income taxes:594639(165)7597701,0601,044
Income tax expense (benefit)(118)(124)61(170)(352)(347)(393)
Net income (loss) available to common stockholders, diluted:476515(105)589418714652

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):476515(105)589418714652
Other comprehensive income6   111
Comprehensive income (loss):482515(105)589419715653
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(15) (6)12(4)3(5)
Comprehensive income (loss), net of tax, attributable to parent:467515(111)601415717648

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: